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of ETRAs may be a potentially useful treatment for ALI caused by
pneumonia.
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Endothelin (ET)-1 plays pleiotropic roles under the pathological
conditions including hypertension, atherosclerosis, heart failure, cancer
development and so on. Also in adaptive immune system, it has been
reported that ET-1 could regulate function of dendritic cells (DCs, one
of antigen-presenting cells) through the ET-1/ETA/ETB autocrine/
paracrine loops. To date, however, a role of ET in autoimmune disease
has not been elucidated. Here, we focused on IL-17 closely related to the
pathogenesis ofmultiple sclerosis (MS) and investigated the effect of ET
receptor blockers on the production of IL-17 from T lymphocytes.
Lymph node cells (LNC) from mice at 8 days post-immunization with
MOG35–55were stimulated in vitrowithMOG35–55 in the presence or
absence of ETR blocker (BQ123 or BQ788). An enzyme-linked
immunosorbent assay revealed that the MOG35–55-induced IL-17
production was signiﬁcantly inhibited by BQ123 but not BQ788.
Consistent with ELISA for IL-17, the frequency of CD4+ T cells
producing IL-17 was reduced by BQ123. To further elucidate the
mechanism for ET-mediated IL-17 production, in vitro model of Th17
differentiationwas conducted. In condition medium of naïve T cells put
under the differentiating condition for 72 h, the spontaneous release of
IL-17 was increased, which was insensitive to BQ123. After the 72 h-
differentiation, however, the anti-CD3/CD28 antibodies-induced IL-17
production from T cells was signiﬁcantly inhibited by BQ123. These
results suggest that ET/ETA signaling plays a crucial role in IL-17
production from Th17 and that BQ123 might be expected as a future
therapeutic drug for the MS.
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Objective: In recent years, several studies demonstrated that
bosentan induced clinical and hemodynamic improvement in candi-
dates for right heart bypass surgery. We hypothesized that the
endothelin system may play an important role in maintaining
vasoconstriction in single ventricular physiology before and after right
heart bypass surgery. Methods: Lung biopsy samples from two patients
were subjected to immunohistological analysis. The ﬁrst patient was a
27-year-old female who underwent atrio-pulmonary connection for
tricuspid atresia at 4 years of age. A huge thrombus was noted on an
echocardiogram in the markedly enlarged right atrium. She underwent
the conversion to total cavopulmonary connection. The second
patient was a 3-year-old girl with asplenia syndrome. She underwent
bidirectional Glenn shunt at the age of 10 months. She had bosentan
and beraprost therapy for elevated pulmonary artery pressure and
pulmonary vascular resistance for 33 months. She underwent total
cavopulmonary connection at 3 years of age. Results: Patient 1: strong
positive immunostaining for endothelin-1 (ET-1) was present in
endothelial cells of capillary vessels in this failed Fontan patient, whereas
in normal control, only veryweak staining of ET-1 in endothelial cellswas
observed. Patient 2: there were many ET-1 positive cells in the
interstitium of alveolar wall. Most, but not all, of these cells expressed
endothelin converting enzyme-1. Conclusions: The endothelin system
may have distinct roles in the pulmonary circulation in patients with
single ventricular physiology. The results of this preliminary study
warrant further investigations.
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